Industry

Systemic Sclerosis (SSc) is a life-threatening autoimmune disease that causes severe inflammation and fibrosis, while Chronic Pruritus of Unknown Origin (CPUO) is characterized by a persistent, chronic itch with an unknown cause1-3 Nemolizumab is the first approved monoclonal antibody that specifically targets the IL-31 receptor alpha, inhibiting the signaling of IL-31. It is approved for … [Read more…]

DALLAS–(BUSINESS WIRE)–Forte Biosciences, Inc. (Nasdaq: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced that it has commenced an underwritten public offering of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of common stock. In addition, Forte expects to grant … [Read more…]

SAN FRANCISCO–(BUSINESS WIRE)–A new investigative report from HIPAA compliant email provider Paubox has exposed a hidden security failure in Microsoft 365 and Google Workspace, two of the most widely used email platforms. Despite claims of encryption and compliance, both platforms fail under real-world conditions that could expose sensitive information without the sender or receiver knowing. … [Read more…]

MOUNT PROSPECT, Ill.–(BUSINESS WIRE)–Rauland®, a global leader in healthcare clinical communications and workflow solutions and a subsidiary of AMETEK, Inc., today announced the expansion of its Vendor Integration Partner (VIP) Program to include leading virtual care platforms Artisight, hellocare.ai, and NESA. This strategic advancement reaffirms Rauland’s commitment to shaping a more connected and responsive healthcare … [Read more…]

Promega Tailored R&D Solutions (TRS) services are now listed on Scientist.com and Science Exchange. These platforms streamline access to customized Promega technologies and R&D collaboration. TRS is a collaborative partner that works with drug discovery researchers to build bespoke solutions to unique problems and perform screening services.   MADISON, Wis.–(BUSINESS WIRE)–Promega Tailored R&D Solutions (TRS) … [Read more…]

The approval in China is supported by a robust local clinical development program confirming the drug’s safety, tolerability, and efficacy profile The launch strengthens Zambon’s presence in China and marks a significant step in the company’s commitment to global therapeutic innovation in respiratory diseases, reflecting its dedicated focus on both clinical research and patient care … [Read more…]

FUJISAWA, Japan & BOSTON–(BUSINESS WIRE)–Axcelead Drug Discovery Partners, Inc. (Axcelead DDP) and Superluminal Medicines, Inc. (Superluminal) announced the intention to collaborate on drug discovery targeting specific molecular mechanisms associated with challenging biological targets. The two companies have built a strong relationship through prior collaborations. Axcelead DDP provided high-quality in vivo pharmacological evaluations of proprietary compounds … [Read more…]

PRINCETON, N.J.–(BUSINESS WIRE)–ArrePath, a company applying its proprietary artificial intelligence and machine learning platform together with deep R&D technical expertise to address the challenge of best-in-class antibacterial drug discovery, announced several business updates. First, the company has raised the next round of financing to advance its pipeline and continue to expand the scope and capabilities … [Read more…]

Most Recently Serving as President for Oticon, a Division of Demant, Rosenblum Brings 30+ Years of Experience in Medical Technology and Consumer Healthcare to ZEISS HEBRON, Ky.–(BUSINESS WIRE)–ZEISS Vision Care, one of the world’s leading manufacturers of eyeglass lenses and ophthalmic instruments, announced today that Gary Rosenblum has been named President and Chief Executive Officer … [Read more…]

SALT LAKE CITY–(BUSINESS WIRE)–#ArtificialIntelligence–Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the successful mapping of conserved therapeutic targets within the measles virus (MeV) genome using BioSeeker™, the company’s proprietary AI-powered discovery engine. Amid rising measles outbreaks worldwide, this breakthrough marks a foundational step … [Read more…]